How big is Walgreens Boots Alliance, Inc.?

As of Jun 18, Walgreens Boots Alliance, Inc. has a market capitalization of 13,374.50 million, with net sales of 151,945.00 million and a net profit of -7,489.00 million over the latest four quarters. As of Aug 24, the company reported shareholder's funds of 10,445.00 million and total assets of 81,037.00 million.

Market Cap: As of Jun 18, Walgreens Boots Alliance, Inc. has a market capitalization of 13,374.50 million, classifying it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Walgreens Boots Alliance, Inc. reported net sales of 151,945.00 million and a net profit of -7,489.00 million.<BR><BR>Balance Sheet Snapshot: As of Aug 24, the company reported shareholder's funds of 10,445.00 million and total assets of 81,037.00 million.

What does Walgreens Boots Alliance, Inc. do?

Walgreens Boots Alliance, Inc. is a pharmacy-led health and wellbeing holding company with a market cap of approximately $13.37 billion, reporting net sales of $38.59 billion and a net loss of $4.04 billion as of February 2025. Key metrics include a dividend yield of 322.73% and a debt-to-equity ratio of 1.32.

Overview: <BR>Walgreens Boots Alliance, Inc. is a pharmacy-led health and wellbeing holding company operating in the Pharmaceuticals & Biotechnology industry with a large-cap market presence.<BR><BR>Financial Snapshot: <BR>Net Sales: 38,588 Million (Quarterly Results - Feb 2025) <BR>Net Profit: -4,036 Million (Quarterly Results - Feb 2025) <BR>Market cap: USD 13,374.50 Million (Large Cap)<BR><BR>Key Metrics: <BR>Dividend Yield: 322.73% <BR>Debt Equity: 1.32 <BR>Return on Equity: -9.46% <BR>Price to Book: 1.88<BR><BR>Contact Details: <BR>Address: 108 Wilmot Rd, DEERFIELD IL: 60015-5145 <BR>Tel: 1 847 3152500 <BR>Fax: 1 302 6365454 <BR>Website: http://www.walgreensbootsalliance.com/

Should I buy, sell or hold Walgreens Boots Alliance, Inc.?

Who are in the management team of Walgreens Boots Alliance, Inc.?

As of March 2022, the management team of Walgreens Boots Alliance, Inc. includes Executive Chairman James Skinner, CEO Stefano Pessina, Lead Independent Director William Foote, and several Independent Directors: Jose Almeida, Janice Babiak, David Brailer, and Ginger Graham. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Walgreens Boots Alliance, Inc. includes:<BR><BR>- Mr. James Skinner, Executive Chairman of the Board<BR>- Mr. Stefano Pessina, Executive Vice Chairman of the Board and Chief Executive Officer<BR>- Mr. William Foote, Lead Independent Director<BR>- Mr. Jose Almeida, Independent Director<BR>- Ms. Janice Babiak, Independent Director<BR>- Dr. David Brailer, Independent Director<BR>- Ms. Ginger Graham, Independent Director<BR><BR>This team is responsible for overseeing the company's strategic direction and operations.

Is Walgreens Boots Alliance, Inc. overvalued or undervalued?

As of March 28, 2024, Walgreens Boots Alliance is considered risky and overvalued due to a negative P/E ratio, low ROE of -9.46%, and unfavorable valuation metrics, despite a recent 1-year return of 29.51% that outperformed the S&P 500, while suffering a significant 5-year decline of -69.09%.

As of 28 March 2024, the valuation grade for Walgreens Boots Alliance, Inc. has moved from very attractive to risky, indicating a shift in investor sentiment. The company appears to be overvalued, particularly given its negative P/E ratio and low ROE of -9.46%. Key ratios include a Price to Book Value of 1.86, an EV to EBITDA of 7.86, and an EV to Sales of 0.15, which suggest that the company's valuation metrics are not favorable compared to its financial performance.<BR><BR>In comparison to its peers, Walgreens Boots Alliance has a significantly lower EV to EBITDA ratio of 6.8577, indicating it is trading at a discount relative to its industry. The stock's recent performance shows a 1-year return of 29.51%, outperforming the S&P 500's 17.14% return, but the longer-term perspective reveals a troubling 5-year decline of -69.09% compared to the S&P's 96.61% gain. This stark contrast in long-term performance reinforces the notion that Walgreens Boots Alliance is currently overvalued.

Is Walgreens Boots Alliance, Inc. technically bullish or bearish?

As of August 5, 2025, Walgreens Boots Alliance shows a bullish trend with a 28.4% year-to-date return, but caution is advised due to mixed signals from the Dow Theory and Bollinger Bands.

As of 5 August 2025, the technical trend for Walgreens Boots Alliance, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the Dow Theory shows a bearish signal on the weekly timeframe, which adds some caution. <BR><BR>In terms of performance, the stock has returned 28.4% year-to-date compared to the S&P 500's 12.22%, and it has a 1-year return of 29.51% versus the S&P 500's 17.14%. Despite the overall bullish indicators, the mixed signals from the Dow Theory and Bollinger Bands suggest a need for careful monitoring.